These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 7495939)

  • 21. Gastro-oesophageal reflux disease in The Netherlands. Results of a multicentre pH study.
    Smout AJ; Geus WP; Mulder PG; Stockbrügger RW; Lamers CB
    Scand J Gastroenterol Suppl; 1996; 218():10-5. PubMed ID: 8865445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Appropriate acid suppression for the management of gastro-oesophageal reflux disease.
    Bell NJ; Burget D; Howden CW; Wilkinson J; Hunt RH
    Digestion; 1992; 51 Suppl 1():59-67. PubMed ID: 1397746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
    Huang JQ; Hunt RH
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. History of acid suppression: focus on the hospital setting.
    Garnett WR
    Pharmacotherapy; 2003 Oct; 23(10 Pt 2):56S-60S. PubMed ID: 14587958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton pump inhibitors in the treatment of gastro-oesophageal reflux disease.
    Tolman KG; Chandramouli J; Fang JC
    Expert Opin Pharmacother; 2000 Sep; 1(6):1171-94. PubMed ID: 11249486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of proton pump inhibitors in the treatment of gastro-oesophageal reflux disease.
    Bardhan KD
    Aliment Pharmacol Ther; 1995; 9 Suppl 1():15-25. PubMed ID: 7495937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histamine receptor antagonists, proton pump inhibitors and their combination in the treatment of gastro-oesophageal reflux disease.
    Katz PO; Tutuian R
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):371-84. PubMed ID: 11403533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prokinetic approach to treatment of gastroesophageal reflux disease.
    Achem SR; Robinson M
    Dig Dis; 1998; 16(1):38-46. PubMed ID: 9549035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacoeconomic issues of the treatment of gastroesophageal reflux disease.
    Storr M; Meining A; Allescher HD
    Expert Opin Pharmacother; 2001 Jul; 2(7):1099-108. PubMed ID: 11583061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New therapeutic options in the treatment of GERD and other acid-peptic disorders. Based on a presentation by Duane D. Webb, MD, FACG.
    Am J Manag Care; 2000 May; 6(9 Suppl):S467-75. PubMed ID: 10977486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nocturnal acid breakthrough: pH, drugs and bugs.
    Tutuian R; Katz PO; Castell DO
    Eur J Gastroenterol Hepatol; 2004 May; 16(5):441-3. PubMed ID: 15097034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic approaches to reflux disease, focusing on acid secretion.
    Kinoshita Y; Adachi K; Fujishiro H
    J Gastroenterol; 2003 Mar; 38 Suppl 15():13-9. PubMed ID: 12698865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton pump inhibitors in the management of gastroesophageal reflux disease.
    Hrelja N; Zerem E
    Med Arh; 2011; 65(1):52-5. PubMed ID: 21534455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How do we offer clinical relief to patients with gastro-oesophageal reflux disease?
    Galmiche JP
    Eur J Gastroenterol Hepatol; 2000 Jun; 12 Suppl 1():S3-6. PubMed ID: 10929891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical treatment of gastro-oesophageal reflux disease.
    De Giorgi F; Savarese MF; Atteo E; Leone CA; Cuomo R
    Acta Otorhinolaryngol Ital; 2006 Oct; 26(5):276-80. PubMed ID: 17345932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effect of H
    Shim YK; Kim N
    Korean J Gastroenterol; 2017 Jul; 70(1):4-12. PubMed ID: 28728310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Roles of gastric acid and pH in the pathogenesis of gastro-oesophageal reflux disease.
    Dent J
    Scand J Gastroenterol Suppl; 1994; 201():55-61. PubMed ID: 8047825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimizing symptom relief and preventing complications in adults with gastro-oesophageal reflux disease.
    Savarino V; Dulbecco P
    Digestion; 2004; 69 Suppl 1():9-16. PubMed ID: 15001830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastroesophageal reflux in pregnancy: a systematic review on the benefit of raft forming agents.
    Quartarone G
    Minerva Ginecol; 2013 Oct; 65(5):541-9. PubMed ID: 24096290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of H2 receptor antagonists in the treatment of gastroesophageal reflux disease and its symptoms.
    Tougas G; Armstrong D
    Can J Gastroenterol; 1997 Sep; 11 Suppl B():51B-54B. PubMed ID: 9347179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.